A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy

被引:0
|
作者
William C Jackson
Skyler B Johnson
Darren Li
Corey Foster
Benjamin Foster
Yeohan Song
Matthew Schipper
Mark Shilkrut
Howard M Sandler
Todd M Morgan
Ganesh S Palapattu
Daniel A Hamstra
Felix Y Feng
机构
[1] University of Michigan,Department of Radiation Oncology
[2] Cedars-Sinai,Department of Radiation Oncology
[3] University of Michigan,Department of Urology
来源
关键词
Prostate-specific antigen doubling time; Salvage radiation therapy; Prostate cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy
    Jackson, William C.
    Johnson, Skyler B.
    Li, Darren
    Foster, Corey
    Foster, Benjamin
    Song, Yeohan
    Schipper, Matthew
    Shilkrut, Mark
    Sandler, Howard M.
    Morgan, Todd M.
    Palapattu, Ganesh S.
    Hamstra, Daniel A.
    Feng, Felix Y.
    [J]. RADIATION ONCOLOGY, 2013, 8
  • [2] Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death
    Tilki, Derya
    Chen, Ming-Hui
    Wu, Jing
    Huland, Hartwig
    Graefen, Markus
    Mohamad, Osama
    Cowan, Janet E.
    Feng, Felix Y.
    Carroll, Peter R.
    D'Amico, Anthony V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (13) : 2428 - +
  • [3] Prostate-specific antigen is a predictor of the efficacy of salvage radiation therapy in patients with recurrent prostate cancer after radical prostatectomy
    Bulychkin, P., V
    Tkachev, S., I
    Matveev, V. B.
    Nazarenko, A., V
    [J]. ONKOUROLOGIYA, 2019, 15 (02): : 66 - 72
  • [4] Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era
    Stephenson, Andrew J.
    Kattan, Michael W.
    Eastham, James A.
    Bianco, Fernando J., Jr.
    Yossepowitch, Ofer
    Vickers, Andrew J.
    Klein, Eric A.
    Wood, David P.
    Scardino, Peter T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4300 - 4305
  • [5] Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era
    Stephenson, Andrew J.
    Kattan, Michael W.
    Eastham, James A.
    Klein, Eric A.
    Bianco, Fernando J.
    Vickers, Andrew J.
    Yossepowitch, Ofer
    Scardino, Peter T.
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 649 - 649
  • [6] Prostate-specific antigen doubling time as a prognostic marker in prostate cancer
    James A Eastham
    [J]. Nature Clinical Practice Urology, 2005, 2 : 482 - 491
  • [7] Prostate-specific antigen doubling time as a prognostic marker in prostate cancer
    Eastham, JA
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (10): : 482 - 491
  • [8] Salvage radiotherapy in patients with persisting prostate-specific antigen after radical prostatectomy for prostate cancer
    Bottke, D
    Wiegel, T
    Höcht, S
    Müller, M
    Schostak, M
    Hinkelbein, W
    [J]. ONCOLOGY, 2003, 65 : 18 - 23
  • [9] Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy
    Jackson, William
    Hamstra, Daniel A.
    Johnson, Skyler
    Zhou, Jessica
    Foster, Benjamin
    Foster, Corey
    Li, Darren
    Song, Yeohan
    Palapattu, Ganesh S.
    Kunju, Lakshmi P.
    Mehra, Rohit
    Feng, Felix Y.
    [J]. CANCER, 2013, 119 (18) : 3287 - 3294
  • [10] Gleason pattern 5 as a pathologic predictor of recurrence, development of metastasis, and prostate cancer-specific death for patients receiving salvage radiation therapy following radical prostatectomy
    Jackson, William C.
    Johnson, Skyler B.
    Foster, Corey
    Li, Darren
    Foster, Benjamin
    Song, Yeohan
    Sandler, Howard Mark
    Palapattu, Ganesh S.
    Kunju, Priya
    Mehra, Rohit
    Hamstra, Daniel A.
    Feng, Felix Yi-Chung
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)